WHO cancer agency launches new European Code Against Cancer

14 October 2014
eu-european-union-flag

The specialized cancer agency of the World Health Organization, the International Agency for Research on Cancer (IARC), has launched the fourth edition of the European Code Against Cancer with the participation of the European Commission today.

The new code is the outcome of a two-year collaborative work between cancer specialists, scientists, and other experts from across the European Union. It provides 12 ways to adopt healthier lifestyles and boost cancer prevention across Europe, such as the importance of avoiding tobacco, alcohol, and excessive sun exposure, as well as the benefits of maintaining a healthy body weight and being physically active. It also recommends participation in organized programmes for bowel, breast, and cervical cancer screening.

IARC director Christopher Wild said: “The code raises awareness of the critical role of prevention in the fight against cancer. By adopting the code, all European citizens can take concrete actions for themselves, their friends and families to significantly reduce their risk of developing cancer.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical